Canadian cannabis removal company, MediPharm laboratories Corp. has established they’ve been chosen because of the Mount Sinai Hospital in new york to be involved in a clinical trial focused on having a non-addictive cannabidiol (CBD) gelcap for the treatment opioid addiction.
MediPharm will produce the gelcap utilizing a proprietary hemp-derived CBD formula from certified Jamaican cannabis producer, Timeless Herbal Care Inc.
Dr. Yasmin Hurd of Mount Sinai states they decided to go with MediPharm because of the standard of the company’s products and their experience with pharmaceutical and medical research. Continue reading “Mount Sinai Hospital Partners With MediPharm For Clinical CBD Test”